Companies: 10,795·Total market cap: $144.5T
CytoMed Therapeutics Limited

CytoMed Therapeutics Limited

GDTCNASDAQHealthcare● Active
$1.15
$-0.14(-10.85%)
Market Cap$13607760
P/E Ratio
52W High$3.68
52W Low$0.68

CytoMed Therapeutics Limited(GDTC)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · GDTC · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.32M$0.07M$0.51M$0.37M$0.00M
Cost of Revenue$1.21M$0.02M$0.00M$0.11M$0.00M
Gross Profit($0.89M)$0.05M$0.51M($0.11M)$0.11M
Gross Margin %(computed)-277.74%75.37%99.27%-29.83%
Operating Expenses
R&D Expenses$2.18M$1.95M$1.59M$1.52M$1.09M
G&A Expenses$0.00M$1.70M$0.46M$0.60M$0.59M
Total Operating Expenses$3.63M$3.18M$2.08M$2.17M$1.27M
Operating Income($4.52M)($3.13M)($1.58M)($2.28M)($1.16M)
Operating Margin %(computed)-310.17%-624.51%
Interest Income$0.12M$0.32M$0.28M$0.00M$0.00M
Interest Expense$0.02M$0.02M$0.05M$0.12M$0.12M
Income Before Tax($3.93M)($2.58M)($4.14M)($3.05M)($2.06M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($3.92M)($2.57M)($4.14M)($3.06M)($2.07M)
Net Margin %(computed)-813.99%-835.73%
Per Share & EBITDA
EPS (Basic)$-0.33$-0.22$-0.38$-0.40$-0.30
Wtd Avg Shares11.65M11.54M10.63M7.92M6.93M
EBITDA($4.30M)($2.44M)($3.89M)($1.47M)($1.42M)
EBITDA Margin %(computed)-763.58%-403.07%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · SGD · M

深入了解CytoMed Therapeutics Limited

关于CytoMed Therapeutics Limited(GDTC)损益表

CytoMed Therapeutics Limited(GDTC)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,GDTC实现营收$0.00B,毛利润($0.00B)(毛利率-277.74%),净利润($0.00B)(净利率-1227.07%)。

常见问题

GDTC · 4 问

CytoMed Therapeutics Limited(GDTC)2025财年营收为$0.00B,同比up359.3%。

GDTC revenueGDTC salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09